Informationen:
Fehler:
ID
14882
Beschreibung
Safety and Efficacy Study of Mix Vaccine in Breast Carcinoma Patient; ODM derived from: https://clinicaltrials.gov/show/NCT02338804
Link
https://clinicaltrials.gov/show/NCT02338804
Stichworte
Versionen (1)
- 03.05.16 03.05.16 -
Hochgeladen am
3. Mai 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Breast Neoplasms NCT02338804
Eligibility Breast Neoplasms NCT02338804
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Breast Neoplasms NCT02338804
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Breast Carcinoma Histologic
Item
1.patients diagnosed with breast carcinoma based on histology
boolean
C0678222 (UMLS CUI [1,1])
C0205462 (UMLS CUI [1,2])
C0205462 (UMLS CUI [1,2])
Evaluable Disease Lesion | imaging studies
Item
2.evaluable lesions on imaging study
boolean
C1516986 (UMLS CUI [1,1])
C0221198 (UMLS CUI [1,2])
C1881134 (UMLS CUI [2])
C0221198 (UMLS CUI [1,2])
C1881134 (UMLS CUI [2])
Immunologic Deficiency Syndromes
Item
3.without known immunodeficiency
boolean
C0021051 (UMLS CUI [1])
Age
Item
4.age >18 and <80 years ago
boolean
C0001779 (UMLS CUI [1])
Unable Informed Consent
Item
1.patients is unable or unwilling to sign informed consent
boolean
C1299582 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,2])
Autoimmune Diseases Prednisone treatment | Immunosuppressive drug
Item
2.any autoimmune disorder, which is currently being treated with prednisone or any other immune suppressive medication
boolean
C0004364 (UMLS CUI [1,1])
C0747791 (UMLS CUI [1,2])
C0499076 (UMLS CUI [2])
C0747791 (UMLS CUI [1,2])
C0499076 (UMLS CUI [2])
HIV Seropositivity | Positive rpr
Item
3.positive hiv and/or rpr (rapid plasma reagin)
boolean
C0019699 (UMLS CUI [1])
C0240917 (UMLS CUI [2])
C0240917 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
4.female patient who is pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
patient not eligible | clinical research investigator
Item
5.patients, based on the opinion pf the investigator, should not be enrolled into this study
boolean
C3242266 (UMLS CUI [1])
C1552025 (UMLS CUI [2])
C1552025 (UMLS CUI [2])
Vaccines Cancer treatment | Biological Immunotherapy
Item
6.prior anti-cancer vaccine or biological immunotherapy
boolean
C0042210 (UMLS CUI [1,1])
C0920425 (UMLS CUI [1,2])
C1511146 (UMLS CUI [2])
C0920425 (UMLS CUI [1,2])
C1511146 (UMLS CUI [2])
Hypersensitivity Chemical Ingredients Investigational New Drug
Item
7.allergic to any known ingredient of the mv compound
boolean
C0020517 (UMLS CUI [1,1])
C0085993 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C0085993 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])